Health insurers sink after proposal points to near-flat Medicare Advantage rate increase for 2027
Shares of major U.S. health insurers fell sharply after federal officials proposed a 0.09% average increase in Medicare Advantage payments for 2027, far below Wall Street expectations and raising fears of tighter margins and benefit reductions.
Health insurer shares slid hard on January 27, 2026 after the U.S. government proposed keeping Medicare Advantage payment growth nearly flat in 2027. The draft approach points to an average payment increase of about 0.09%, a level that caught analysts and investors off guard after years in which rate updates were materially higher.
UnitedHealth, Humana and CVS Health were among the biggest decliners, reflecting how dependent large managed-care businesses are on predictable federal reimbursement trends. Investors interpreted the proposal as a direct hit to future margins at a time when insurers have already been wrestling with higher medical costs and heightened scrutiny of Medicare Advantage practices.
The proposal’s impact goes beyond a single percentage point. Medicare Advantage plans are priced and designed far in advance, and a low rate update can force insurers to respond by trimming benefits, tightening provider networks, exiting certain counties, or shifting more costs to consumers. Analysts warned that if the final rate remains close to the proposal, insurers may be pushed toward difficult tradeoffs to protect profitability in 2027.
The government also proposed changes affecting how diagnoses are counted for payment calculations, another sensitive pressure point for the industry. Those technical adjustments matter because even small coding changes can reshape payments across millions of members, and companies have been under ongoing regulatory and legal attention related to risk scoring and billing practices.
Insurers and industry groups are expected to lobby aggressively during the comment period, arguing that inadequate updates could reduce plan choices or raise out-of-pocket costs for seniors. Officials, meanwhile, have framed the effort as part of ensuring the program works better for beneficiaries and controlling costs in a major federal entitlement.
Next steps are crucial. The proposal is not final, and policymakers can revise it before locking in 2027 rates later in the year. Until then, the market’s message is clear: Medicare Advantage policy risk is back at the center of the health-care trade, and headline surprises can move the entire group in a single session.